Chlorogenic acid (CGA) metabolites-containing serum from CGA-treated normal mice decreases lipid accumulation and stimulates cholesterol efflux from RAW264.7 cells. by Chongming Wu (169161)

“…<p>Normal C57BL/6J mice were orally gavaged with 400 mg/kg of CGA or equal volume of distilled water for 3 days and blood was collected at 45 min after the final treatment. 1% (v/v) of serum from CGA-treated normal mice (S_CGA) significantly decreased oxLDL-induced neutral lipid accumulation (A) and total cholesterol (B), and stimulates cholesterol efflux (C) in RAW264.7 cells as compared with that from distilled water-treated animals (S_NC). …”

Cdk5 inhibition by olomoucine prevents the fragmentation of the Golgi and decreases Tau secretion. by Nguyen-Vi Mohamed (323606)

Increase of total proteinuria and decrease of renal function in mice lacking CD73. by Cornelia Blume (321209)

N protein of SVCV decreases K48-linked ubiquitination of p53. by Shun Li (330132)

“…<b>(D)</b> N protein decreases the ubiquitination of p53. EPC cells were seeded in 10 cm² dishes and transfected with 5 μg p53-Myc, 5 μg N-Flag or empty vector, and 1 μg HA-Ub. …”

Mefunidone decreased collagen I, collagen III, α-smooth muscle actin (α-SMA) and fibronectin (FN) expression in the obstructive kidneys after UUO at 14 days. by Chunyan Liu (44864)

“…<p><b><i>A</i>.</b> Mefunidone affected collagen I (left) and collagen III (right) protein expression in the obstructed kidneys stained by immunohistochemistry (×200). …”

SWSs measured for cell-laden gels with 5 mg/ml Matrigel and 1 mg/ml (M5C1), 2 mg/ml (M5C2), and 3 mg/ml (M5C3) collagen type I. by Shao-Lun Lu (12360135)

SRTCX1003 decreases LPS-stimulated cytokine production <i>in vivo</i>. by Hongying Yang (131218)

Expression of MHC I is decreased by P2X7R activation. by Alberto Baroja-Mazo (441935)

Buprenorphine decreased plasma BDNF and serotonin content and altered signaling molecule expression. by Chih-Jen Hung (499000)

AZA decreased AQP1protein content by promoting AQP1 degradation. by Jianzhao Zhang (133200)

BCG-AS−Ndk has decreased intracellular survival due to increased phagolysosome fusion. by Jim Sun (367834)

Cellular stress decreases TDP-43 levels in patient neurons with the TDP-43 A90V mutation. by Zhijun Zhang (315079)

Subjects:

ATG 5 down-regulation decreases human A53T ASYN-induced death in rat cortical neurons. by Maria Xilouri (264240)

Cysteamine decreased metastasis and prolonged survival in an orthotopic pancreatic cancer mouse model. by Toshio Fujisawa (169513)

Human RBS cells showed severely slow proliferation and decreased protein translation. by Baoshan Xu (158726)

EphA4 immunostaining is decreased adjacent to injury site in ephrin-A5-Fc treated mice. by Yona Goldshmit (205708)

“…<p>Immunohistochemical analysis of (A,B) GFAP, (C–F) EphA4 and (G,H) CSPG expression at 2 weeks after spinal cord hemisection and 2 weeks of ephrin-A5-Fc treatment indicated that there was robust GFAP staining in both treated and control mice (A,B). …”

The Impact of Prophylactic Dexamethasone on Nausea and Vomiting after Thyroidectomy: A Systematic Review and Meta-Analysis by Zhenhong Zou (645858)

“…Dexamethasone 8–10<b> </b>mg had a significantly greater effect for reducing the incidence of PONV than dexamethasone 1.25–5<b> </b>mg. …”

Inhibition of PARP-1 decreased the poly(ADP-ribosyl)ation of Sp1. by Liu Yang (23752)

Estrogen treatment decreases disease severity and the expression of pro-inflammatory cytokines and chemokines. by Lydia C. Cook (548045)

Inhibition of SNAI2 expression decreases the sensitivity to chemotherapy drugs of HCC cells. by Xin-Yu Zhao (3228756)